IDEAYA Biosciences, Inc. (IDYA) Presents at Citi's 2025 SMID Cap Biopharma Call Series Transcript

Core Insights - The event features a virtual fireside chat with Yujiro Hata, CEO of IDEAYA, hosted by Yigal Nochomovitz, a biotech analyst at Citigroup [1][2] Group 1 - The discussion is part of a series aimed at engaging with C-suite executives in the biotech industry [1] - Participants are encouraged to submit questions for the CEO during the conversation [2]